Evaluating the Minimal Clinically Important Difference of the King’s Sarcoidosis Questionnaire in a Multicenter Prospective Study
Robert P. Baughman(University of Cincinnati), Surinder S. Birring(King's College Hospital), Jennifer L. Beaumont(Northwestern University), Nabeel Hamzeh(American Thoracic Society), Marc A. Judson(Cleveland Clinic), Dominique Valeyre(Inserm), Lisa A. Maier(National Jewish Health), Edward S. Chen(American Thoracic Society), Rebecca S. Reeves, Nadera Sweiss(University of Illinois Chicago), Jan C. Grutters(University Medical Center Utrecht), Elyse E. Lower(University of Cincinnati), Daniel A. Culver(Cleveland Clinic), Noopur Singh(Pulmonary Fibrosis Foundation)
Cited by 33
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
|Immunity|2009|2.3k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
|The Lancet|2011|2.1k
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
|Diabetes Care|2007|1.5k
Sarcoidosis
|The Lancet|2013|1.1k